Business Context and Reporting Period
This Form 8-K filing by AVROBIO, Inc. (not Tectonic Therapeutic, Inc.) reports on the 2019 Annual Meeting of Stockholders held on June 11, 2019. The registrant is a Delaware corporation with its principal executive offices in Cambridge, MA, and its common stock trades on the Nasdaq Global Select Market under the symbol AVRO. The company is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results rather than financial performance.
Material Changes and Voting Results
The primary material event reported is the outcome of the stockholder vote at the Annual Meeting. A quorum was present, and the following proposals were approved:
- Election of Directors: Stockholders elected two Class I director nominees to serve until the 2022 annual meeting:
- Christopher Paige, Ph.D.: Received 16,771,213 votes for, 3,051,618 votes withheld, and 2,061,714 broker non-votes.
- Philip Vickers, Ph.D.: Received 19,071,604 votes for, 751,227 votes withheld, and 2,061,714 broker non-votes.
- Ratification of Auditors: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
- Votes For: 21,863,304
- Votes Against: 20,741
- Abstentions: 500
- Broker Non-Votes: None reported
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of voting results pursuant to Item 5.07.
Key Facts for Investor Verification
- Verify the company name discrepancy: The input metadata referenced "Tectonic Therapeutic, Inc.," but the filing is for AVROBIO, Inc.
- Confirm the tenure of the newly elected directors (Christopher Paige and Philip Vickers) extends through the 2022 annual meeting.
- Note the significant number of broker non-votes (2,061,714) on the director election proposals, which may indicate institutional holdings where brokers lacked discretionary voting power.
- Confirm that Ernst & Young LLP has been officially retained as the auditor for the fiscal year ending December 31, 2019.